NS Partners’s Intuitive Surgical ISRG Stock Holding History

NS Partners’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.2M	Sell	45,873 -25,614	-36%	-$11.2M	0.78%	40
2026 Q1	$33M	Sell	71,487 -768	-1%	-$389K	1.48%	23
2025 Q4	$40.9M	Buy	72,255 +49	+0.1%	+$26.1K	1.6%	15
2025 Q3	$32.3M	Buy	72,206 +9	+0%	+$4.32K	1.25%	21
2025 Q2	$39.2M	Sell	72,197 -1,598	-2%	-$836K	1.6%	16
2025 Q1	$36.5M	Buy	73,795 +1,241	+2%	+$686K	1.61%	20
2024 Q4	$37.9M	Sell	72,554 -964	-1%	-$502K	1.57%	19
2024 Q3	$36.1M	Buy	73,518 +1,632	+2%	+$760K	1.52%	22
2024 Q2	$32M	Buy	71,886 +312	+0.4%	+$124K	1.45%	22
2024 Q1	$28.6M	Buy	71,574 +566	+0.8%	+$214K	1.32%	26
2023 Q4	$24M	Buy	71,008 +473	+0.7%	+$141K	1.16%	32
2023 Q3	$20.6M	Sell	70,535 -406	-0.6%	-$127K	1.11%	34
2023 Q2	$24.3M	Sell	70,941 -504	-0.7%	-$152K	1.28%	31
2023 Q1	$18.3M	Buy	71,445 +74	+0.1%	+$18.2K	1.03%	46
2022 Q4	$18.9M	Buy	71,371 +371	+0.5%	+$90.5K	1.14%	40
2022 Q3	$13.3M	Buy	71,000 +2,879	+4%	+$618K	0.86%	52
2022 Q2	$13.7M	Buy	68,121 +569	+0.8%	+$133K	0.83%	50
2022 Q1	$20.4M	Sell	67,552 -3,040	-4%	-$888K	1.09%	37
2021 Q4	$25.4M	Buy	70,592 +359	+0.5%	+$124K	1.19%	33
2021 Q3	$23.3M	Buy	70,233 +183	+0.3%	+$61.5K	1.19%	35
2021 Q2	$21.5M	Buy	70,050 +45	+0.1%	+$12.6K	1.13%	35
2021 Q1	$17.2M	Sell	70,005 -1,986	-3%	-$500K	1%	38
2020 Q4	$19.6M	Buy	71,991 +180	+0.3%	+$44.7K	1.15%	34
2020 Q3	$17M	Buy	71,811 +8,136	+13%	+$1.83M	1.12%	39
2020 Q2	$12.1M	Buy	63,675 +21,813	+52%	+$3.91M	0.89%	48
2020 Q1	$6.91M	Buy	41,862 +6,264	+18%	+$1.15M	0.64%	56
2019 Q4	$7.01M	Buy	35,598 +168	+0.5%	+$31.5K	0.56%	60
2019 Q3	$6.38M	Buy	35,430 +561	+2%	+$97K	0.57%	59
2019 Q2	$6.1M	Buy	+34,869	New	+$5.97M	0.56%	61

Other funds holding ISRG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

NS Partners's ISRG Position: Q2 2026 in Review

NS Partners reduced its Intuitive Surgical (ISRG) stake by 36% in Q2 2026, selling an estimated $11.2M and leaving 45,873 shares worth $18.2M. The position accounts for 0.78% of the portfolio, ranked #40.

NS Partners first reported a position in ISRG in Q2 2019 and has held it in 29 quarters since. The position peaked at $40.9M in Q4 2025. 2,250 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

NS Partners held 45,873 shares of Intuitive Surgical worth $18.2M as of Q2 2026.
NS Partners sold 25,614 Intuitive Surgical shares in Q2 2026, an estimated $11.2M.
Intuitive Surgical made up 0.78% of NS Partners's portfolio in Q2 2026, its #40 holding.
NS Partners first reported a position in Intuitive Surgical in Q2 2019 and has held it in 29 quarters since.
NS Partners's Intuitive Surgical position peaked at $40.9M in Q4 2025.
2,250 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on NS Partners's 13F filing for Q2 2026, filed 13 Aug 2026.